The consistent activation of keratoconus-associated pathways—including TGF-β/SMAD signaling, ECM-receptor interactions, and inflammatory responses—across all cell types indicates that pathological curvature drives disease-relevant molecular programs regardless of stromal cell phenotype. This evidence concerns the gene TGFB1 and keratoconus.